It’s in our national security interest to stand by democratic allies in our hemisphere. Today, Paraguay and the United States continue to advance the security, stability, and economic prosperity in our region. U.S. Senators Marco Rubio (R-FL), Ben Cardin (D-MD), and...
News
Latest News
Rubio, Cardin y Colegas Presentan Resolución que Conmemora las Relaciones de EE.UU. con Paraguay
Es de interés para nuestra seguridad nacional mantener una postura firme junto a nuestros aliados democráticos en nuestro hemisferio. Hoy, EE.UU. y Paraguay siguen avanzando en temas de seguridad, al igual que sobre la estabilidad y prosperidad económica de nuestra...
Rubio Grills Biden on EV-focused China Tariffs
President Biden is increasing tariffs on imported Chinese electric vehicles (EVs), with no comparable tariff increase on Chinese internal combustion engine vehicles. This misguided half-solution, rooted in President Biden’s radical climate agenda, ignores the true...
Rubio, Moolenaar, Colleagues Urge Washington to Establish Sister City Ties With Taiwan
Since 1984, Washington, D.C. has maintained sister city ties with Beijing, despite Communist China’s well-documented human rights abuses and acts of genocide. The Chinese Communist Party has long sought to isolate Taiwan on the international stage, both diplomatically...
ICYMI: Rubio Joins The Clay Travis and Buck Sexton Show
U.S. Senator Marco Rubio (R-FL) joined the Clay Travis and Buck Sexton Show to discuss the pro-Hamas college encampments, Democrats’ mixed Israel messaging, and more. See below for highlights and listen to the full interview here. On the politically motivated trials...
ICYMI: Rubio: Earth-week Housing Rule Puts “Planet” Over People
Biden Is Making It Harder to Buy Homes — Just to Please Green Radicals and Wall Street U.S. Senator Marco Rubio (R-FL) May 12, 2024 New York Post …HUD is issuing a new “energy-saving” rule that will instead increase the cost of building homes for federally assisted...
Transcript: Rubio Forces NIH to Admit There Is No Conclusive Safety Data on the Impact of Puberty Blockers on Youth
Washington, D.C. — U.S. Senator Marco Rubio (R-FL) questioned Dr. Lawrence Tabak, Acting Director of the National Institutes of Health, during a Senate Appropriations Subcommittee on Labor, Health and Human Services hearing. Tabak acknowledged there are no long-term studies on the risks associated with the off-label use of puberty blockers by minors.
A video of Rubio’s questioning can be found here and a transcript of the exchange is below.
RUBIO: Dr. Tabak, let me start with this question. We’ve recently seen…that the Biden Administration and others in the policy realm have been actively promoting and supporting the use of things like puberty blockers and hormone therapy for young boys and girls.
I want to limit my question to minors for what they have termed “gender transforming care.” That’s not an FDA-approved use for puberty blockers and hormone therapy, I don’t believe, in any people, but especially in minors. So, as the NIH is America’s medical research agency, what work have we done at NIH… to determine if this non FDA-approved use of these medicines, this off-label use of these medicines, is appropriate for minors seeking gender transforming care?
TABAK: So, NIH funds a small number of observational studies to gather the data on the effects of treatments that transgender youth and their parents have chosen. And there are also a small number of studies that describe the health issues and risks, including HIV, that are unique to to these transgender youth. But all of the research in this space is observational. We do no interventional work.
RUBIO: I guess my question is…[it’s] one thing i[f] a decision [is] made by an adult, right? And, especially given the irreversible nature of some of these treatments, isn’t there some wisdom in the notion that, before policymakers are out there promoting the off-label use of medications that lead to permanent changes, that there be some more research done on [the] impact [it will have] five, ten, 15, 20 years from now?
TABAK: So, as you know, transgender youth are more vulnerable to depression, anxiety, [engagement] in self-harm. And so it is important that we examine and evaluate the potential effects of these treatments. Researchers are observing longer-term psychological impact of these protocols. And so by by looking at individuals, transgender youth with and without histories of puberty suppression, we will be able to better answer the types of questions that you’re posing.
RUBIO: Yeah, I guess that’s my point. My point is, we don’t know what its long term implications are when we weigh the cost and the benefits. The FDA hasn’t approved this and yet we have policymakers promoting it, and I think that’s an important point.
We clearly don’t want anybody harming themselves…but…these policy decisions are being made on the basis of observational guidance and, by your own admission, without any sort of long term trajectory on its holistic impact.